Global CAR T-Cell Therapy Agents Supply, Demand and Key Producers, 2024-2030

Description

The global CAR T-Cell Therapy Agents market size is expected to reach $ 592.9 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.

This report studies the global CAR T-Cell Therapy Agents demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CAR T-Cell Therapy Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR T-Cell Therapy Agents that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CAR T-Cell Therapy Agents total market, 2019-2030, (USD Million)
Global CAR T-Cell Therapy Agents total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: CAR T-Cell Therapy Agents total market, key domestic companies and share, (USD Million)
Global CAR T-Cell Therapy Agents revenue by player and market share 2019-2024, (USD Million)
Global CAR T-Cell Therapy Agents total market by Type, CAGR, 2019-2030, (USD Million)
Global CAR T-Cell Therapy Agents total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global CAR T-Cell Therapy Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), CARsgen Therapeutics and Autolus Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR T-Cell Therapy Agents market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global CAR T-Cell Therapy Agents Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global CAR T-Cell Therapy Agents Market, Segmentation by Type
    CD19-targeted
    BCMA-targeted

Global CAR T-Cell Therapy Agents Market, Segmentation by Application
    Lymphoma
    Multiple Myeloma

Companies Profiled:
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite
    CARsgen Therapeutics (Pipeline)
    CARsgen Therapeutics
    Autolus Therapeutics
    Sorrento Therapeutics
    Mustang Bio
    Bluebird Bio
    Cellectis
    Allogene Therapeutics
    Celyad

Key Questions Answered
1. How big is the global CAR T-Cell Therapy Agents market?
2. What is the demand of the global CAR T-Cell Therapy Agents market?
3. What is the year over year growth of the global CAR T-Cell Therapy Agents market?
4. What is the total value of the global CAR T-Cell Therapy Agents market?
5. Who are the major players in the global CAR T-Cell Therapy Agents market?

Table of Contents

1 Supply Summary
    1.1 CAR T-Cell Therapy Agents Introduction
    1.2 World CAR T-Cell Therapy Agents Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World CAR T-Cell Therapy Agents Total Market by Region (by Headquarter Location)
        1.3.1 World CAR T-Cell Therapy Agents Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States CAR T-Cell Therapy Agents Market Size (2019-2030)
        1.3.3 China CAR T-Cell Therapy Agents Market Size (2019-2030)
        1.3.4 Europe CAR T-Cell Therapy Agents Market Size (2019-2030)
        1.3.5 Japan CAR T-Cell Therapy Agents Market Size (2019-2030)
        1.3.6 South Korea CAR T-Cell Therapy Agents Market Size (2019-2030)
        1.3.7 ASEAN CAR T-Cell Therapy Agents Market Size (2019-2030)
        1.3.8 India CAR T-Cell Therapy Agents Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 CAR T-Cell Therapy Agents Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 CAR T-Cell Therapy Agents Major Market Trends

2 Demand Summary
    2.1 World CAR T-Cell Therapy Agents Consumption Value (2019-2030)
    2.2 World CAR T-Cell Therapy Agents Consumption Value by Region
        2.2.1 World CAR T-Cell Therapy Agents Consumption Value by Region (2019-2024)
        2.2.2 World CAR T-Cell Therapy Agents Consumption Value Forecast by Region (2025-2030)
    2.3 United States CAR T-Cell Therapy Agents Consumption Value (2019-2030)
    2.4 China CAR T-Cell Therapy Agents Consumption Value (2019-2030)
    2.5 Europe CAR T-Cell Therapy Agents Consumption Value (2019-2030)
    2.6 Japan CAR T-Cell Therapy Agents Consumption Value (2019-2030)
    2.7 South Korea CAR T-Cell Therapy Agents Consumption Value (2019-2030)
    2.8 ASEAN CAR T-Cell Therapy Agents Consumption Value (2019-2030)
    2.9 India CAR T-Cell Therapy Agents Consumption Value (2019-2030)

3 World CAR T-Cell Therapy Agents Companies Competitive Analysis
    3.1 World CAR T-Cell Therapy Agents Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global CAR T-Cell Therapy Agents Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for CAR T-Cell Therapy Agents in 2023
        3.2.3 Global Concentration Ratios (CR8) for CAR T-Cell Therapy Agents in 2023
    3.3 CAR T-Cell Therapy Agents Company Evaluation Quadrant
    3.4 CAR T-Cell Therapy Agents Market: Overall Company Footprint Analysis
        3.4.1 CAR T-Cell Therapy Agents Market: Region Footprint
        3.4.2 CAR T-Cell Therapy Agents Market: Company Product Type Footprint
        3.4.3 CAR T-Cell Therapy Agents Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: CAR T-Cell Therapy Agents Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: CAR T-Cell Therapy Agents Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: CAR T-Cell Therapy Agents Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: CAR T-Cell Therapy Agents Consumption Value Comparison
        4.2.1 United States VS China: CAR T-Cell Therapy Agents Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: CAR T-Cell Therapy Agents Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based CAR T-Cell Therapy Agents Companies and Market Share, 2019-2024
        4.3.1 United States Based CAR T-Cell Therapy Agents Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies CAR T-Cell Therapy Agents Revenue, (2019-2024)
    4.4 China Based Companies CAR T-Cell Therapy Agents Revenue and Market Share, 2019-2024
        4.4.1 China Based CAR T-Cell Therapy Agents Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies CAR T-Cell Therapy Agents Revenue, (2019-2024)
    4.5 Rest of World Based CAR T-Cell Therapy Agents Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based CAR T-Cell Therapy Agents Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies CAR T-Cell Therapy Agents Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World CAR T-Cell Therapy Agents Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 CD19-targeted
        5.2.2 BCMA-targeted
    5.3 Market Segment by Type
        5.3.1 World CAR T-Cell Therapy Agents Market Size by Type (2019-2024)
        5.3.2 World CAR T-Cell Therapy Agents Market Size by Type (2025-2030)
        5.3.3 World CAR T-Cell Therapy Agents Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World CAR T-Cell Therapy Agents Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Lymphoma
        6.2.2 Multiple Myeloma
    6.3 Market Segment by Application
        6.3.1 World CAR T-Cell Therapy Agents Market Size by Application (2019-2024)
        6.3.2 World CAR T-Cell Therapy Agents Market Size by Application (2025-2030)
        6.3.3 World CAR T-Cell Therapy Agents Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis CAR T-Cell Therapy Agents Product and Services
        7.1.4 Novartis CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 Gilead Sciences
        7.2.1 Gilead Sciences Details
        7.2.2 Gilead Sciences Major Business
        7.2.3 Gilead Sciences CAR T-Cell Therapy Agents Product and Services
        7.2.4 Gilead Sciences CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Gilead Sciences Recent Developments/Updates
        7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Details
        7.3.2 Bristol-Myers Squibb Major Business
        7.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product and Services
        7.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Bristol-Myers Squibb Recent Developments/Updates
        7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.4 J & J
        7.4.1 J & J Details
        7.4.2 J & J Major Business
        7.4.3 J & J CAR T-Cell Therapy Agents Product and Services
        7.4.4 J & J CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 J & J Recent Developments/Updates
        7.4.6 J & J Competitive Strengths & Weaknesses
    7.5 JW Therapeutics
        7.5.1 JW Therapeutics Details
        7.5.2 JW Therapeutics Major Business
        7.5.3 JW Therapeutics CAR T-Cell Therapy Agents Product and Services
        7.5.4 JW Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 JW Therapeutics Recent Developments/Updates
        7.5.6 JW Therapeutics Competitive Strengths & Weaknesses
    7.6 FOSUNKite
        7.6.1 FOSUNKite Details
        7.6.2 FOSUNKite Major Business
        7.6.3 FOSUNKite CAR T-Cell Therapy Agents Product and Services
        7.6.4 FOSUNKite CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 FOSUNKite Recent Developments/Updates
        7.6.6 FOSUNKite Competitive Strengths & Weaknesses
    7.7 CARsgen Therapeutics (Pipeline)
        7.7.1 CARsgen Therapeutics (Pipeline) Details
        7.7.2 CARsgen Therapeutics (Pipeline) Major Business
        7.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product and Services
        7.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 CARsgen Therapeutics (Pipeline) Recent Developments/Updates
        7.7.6 CARsgen Therapeutics (Pipeline) Competitive Strengths & Weaknesses
    7.8 CARsgen Therapeutics
        7.8.1 CARsgen Therapeutics Details
        7.8.2 CARsgen Therapeutics Major Business
        7.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Product and Services
        7.8.4 CARsgen Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 CARsgen Therapeutics Recent Developments/Updates
        7.8.6 CARsgen Therapeutics Competitive Strengths & Weaknesses
    7.9 Autolus Therapeutics
        7.9.1 Autolus Therapeutics Details
        7.9.2 Autolus Therapeutics Major Business
        7.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Product and Services
        7.9.4 Autolus Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Autolus Therapeutics Recent Developments/Updates
        7.9.6 Autolus Therapeutics Competitive Strengths & Weaknesses
    7.10 Sorrento Therapeutics
        7.10.1 Sorrento Therapeutics Details
        7.10.2 Sorrento Therapeutics Major Business
        7.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Product and Services
        7.10.4 Sorrento Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Sorrento Therapeutics Recent Developments/Updates
        7.10.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
    7.11 Mustang Bio
        7.11.1 Mustang Bio Details
        7.11.2 Mustang Bio Major Business
        7.11.3 Mustang Bio CAR T-Cell Therapy Agents Product and Services
        7.11.4 Mustang Bio CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Mustang Bio Recent Developments/Updates
        7.11.6 Mustang Bio Competitive Strengths & Weaknesses
    7.12 Bluebird Bio
        7.12.1 Bluebird Bio Details
        7.12.2 Bluebird Bio Major Business
        7.12.3 Bluebird Bio CAR T-Cell Therapy Agents Product and Services
        7.12.4 Bluebird Bio CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Bluebird Bio Recent Developments/Updates
        7.12.6 Bluebird Bio Competitive Strengths & Weaknesses
    7.13 Cellectis
        7.13.1 Cellectis Details
        7.13.2 Cellectis Major Business
        7.13.3 Cellectis CAR T-Cell Therapy Agents Product and Services
        7.13.4 Cellectis CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Cellectis Recent Developments/Updates
        7.13.6 Cellectis Competitive Strengths & Weaknesses
    7.14 Allogene Therapeutics
        7.14.1 Allogene Therapeutics Details
        7.14.2 Allogene Therapeutics Major Business
        7.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Product and Services
        7.14.4 Allogene Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Allogene Therapeutics Recent Developments/Updates
        7.14.6 Allogene Therapeutics Competitive Strengths & Weaknesses
    7.15 Celyad
        7.15.1 Celyad Details
        7.15.2 Celyad Major Business
        7.15.3 Celyad CAR T-Cell Therapy Agents Product and Services
        7.15.4 Celyad CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Celyad Recent Developments/Updates
        7.15.6 Celyad Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 CAR T-Cell Therapy Agents Industry Chain
    8.2 CAR T-Cell Therapy Agents Upstream Analysis
    8.3 CAR T-Cell Therapy Agents Midstream Analysis
    8.4 CAR T-Cell Therapy Agents Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World CAR T-Cell Therapy Agents Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World CAR T-Cell Therapy Agents Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World CAR T-Cell Therapy Agents Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World CAR T-Cell Therapy Agents Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World CAR T-Cell Therapy Agents Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World CAR T-Cell Therapy Agents Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World CAR T-Cell Therapy Agents Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World CAR T-Cell Therapy Agents Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World CAR T-Cell Therapy Agents Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key CAR T-Cell Therapy Agents Players in 2023
    Table 12. World CAR T-Cell Therapy Agents Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global CAR T-Cell Therapy Agents Company Evaluation Quadrant
    Table 14. Head Office of Key CAR T-Cell Therapy Agents Player
    Table 15. CAR T-Cell Therapy Agents Market: Company Product Type Footprint
    Table 16. CAR T-Cell Therapy Agents Market: Company Product Application Footprint
    Table 17. CAR T-Cell Therapy Agents Mergers & Acquisitions Activity
    Table 18. United States VS China CAR T-Cell Therapy Agents Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China CAR T-Cell Therapy Agents Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based CAR T-Cell Therapy Agents Companies, Headquarters (States, Country)
    Table 21. United States Based Companies CAR T-Cell Therapy Agents Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies CAR T-Cell Therapy Agents Revenue Market Share (2019-2024)
    Table 23. China Based CAR T-Cell Therapy Agents Companies, Headquarters (Province, Country)
    Table 24. China Based Companies CAR T-Cell Therapy Agents Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies CAR T-Cell Therapy Agents Revenue Market Share (2019-2024)
    Table 26. Rest of World Based CAR T-Cell Therapy Agents Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies CAR T-Cell Therapy Agents Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies CAR T-Cell Therapy Agents Revenue Market Share (2019-2024)
    Table 29. World CAR T-Cell Therapy Agents Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World CAR T-Cell Therapy Agents Market Size by Type (2019-2024) & (USD Million)
    Table 31. World CAR T-Cell Therapy Agents Market Size by Type (2025-2030) & (USD Million)
    Table 32. World CAR T-Cell Therapy Agents Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World CAR T-Cell Therapy Agents Market Size by Application (2019-2024) & (USD Million)
    Table 34. World CAR T-Cell Therapy Agents Market Size by Application (2025-2030) & (USD Million)
    Table 35. Novartis Basic Information, Area Served and Competitors
    Table 36. Novartis Major Business
    Table 37. Novartis CAR T-Cell Therapy Agents Product and Services
    Table 38. Novartis CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Novartis Recent Developments/Updates
    Table 40. Novartis Competitive Strengths & Weaknesses
    Table 41. Gilead Sciences Basic Information, Area Served and Competitors
    Table 42. Gilead Sciences Major Business
    Table 43. Gilead Sciences CAR T-Cell Therapy Agents Product and Services
    Table 44. Gilead Sciences CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Gilead Sciences Recent Developments/Updates
    Table 46. Gilead Sciences Competitive Strengths & Weaknesses
    Table 47. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 48. Bristol-Myers Squibb Major Business
    Table 49. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product and Services
    Table 50. Bristol-Myers Squibb CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Bristol-Myers Squibb Recent Developments/Updates
    Table 52. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 53. J & J Basic Information, Area Served and Competitors
    Table 54. J & J Major Business
    Table 55. J & J CAR T-Cell Therapy Agents Product and Services
    Table 56. J & J CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. J & J Recent Developments/Updates
    Table 58. J & J Competitive Strengths & Weaknesses
    Table 59. JW Therapeutics Basic Information, Area Served and Competitors
    Table 60. JW Therapeutics Major Business
    Table 61. JW Therapeutics CAR T-Cell Therapy Agents Product and Services
    Table 62. JW Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. JW Therapeutics Recent Developments/Updates
    Table 64. JW Therapeutics Competitive Strengths & Weaknesses
    Table 65. FOSUNKite Basic Information, Area Served and Competitors
    Table 66. FOSUNKite Major Business
    Table 67. FOSUNKite CAR T-Cell Therapy Agents Product and Services
    Table 68. FOSUNKite CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. FOSUNKite Recent Developments/Updates
    Table 70. FOSUNKite Competitive Strengths & Weaknesses
    Table 71. CARsgen Therapeutics (Pipeline) Basic Information, Area Served and Competitors
    Table 72. CARsgen Therapeutics (Pipeline) Major Business
    Table 73. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product and Services
    Table 74. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. CARsgen Therapeutics (Pipeline) Recent Developments/Updates
    Table 76. CARsgen Therapeutics (Pipeline) Competitive Strengths & Weaknesses
    Table 77. CARsgen Therapeutics Basic Information, Area Served and Competitors
    Table 78. CARsgen Therapeutics Major Business
    Table 79. CARsgen Therapeutics CAR T-Cell Therapy Agents Product and Services
    Table 80. CARsgen Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. CARsgen Therapeutics Recent Developments/Updates
    Table 82. CARsgen Therapeutics Competitive Strengths & Weaknesses
    Table 83. Autolus Therapeutics Basic Information, Area Served and Competitors
    Table 84. Autolus Therapeutics Major Business
    Table 85. Autolus Therapeutics CAR T-Cell Therapy Agents Product and Services
    Table 86. Autolus Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Autolus Therapeutics Recent Developments/Updates
    Table 88. Autolus Therapeutics Competitive Strengths & Weaknesses
    Table 89. Sorrento Therapeutics Basic Information, Area Served and Competitors
    Table 90. Sorrento Therapeutics Major Business
    Table 91. Sorrento Therapeutics CAR T-Cell Therapy Agents Product and Services
    Table 92. Sorrento Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Sorrento Therapeutics Recent Developments/Updates
    Table 94. Sorrento Therapeutics Competitive Strengths & Weaknesses
    Table 95. Mustang Bio Basic Information, Area Served and Competitors
    Table 96. Mustang Bio Major Business
    Table 97. Mustang Bio CAR T-Cell Therapy Agents Product and Services
    Table 98. Mustang Bio CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Mustang Bio Recent Developments/Updates
    Table 100. Mustang Bio Competitive Strengths & Weaknesses
    Table 101. Bluebird Bio Basic Information, Area Served and Competitors
    Table 102. Bluebird Bio Major Business
    Table 103. Bluebird Bio CAR T-Cell Therapy Agents Product and Services
    Table 104. Bluebird Bio CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Bluebird Bio Recent Developments/Updates
    Table 106. Bluebird Bio Competitive Strengths & Weaknesses
    Table 107. Cellectis Basic Information, Area Served and Competitors
    Table 108. Cellectis Major Business
    Table 109. Cellectis CAR T-Cell Therapy Agents Product and Services
    Table 110. Cellectis CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Cellectis Recent Developments/Updates
    Table 112. Cellectis Competitive Strengths & Weaknesses
    Table 113. Allogene Therapeutics Basic Information, Area Served and Competitors
    Table 114. Allogene Therapeutics Major Business
    Table 115. Allogene Therapeutics CAR T-Cell Therapy Agents Product and Services
    Table 116. Allogene Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Allogene Therapeutics Recent Developments/Updates
    Table 118. Celyad Basic Information, Area Served and Competitors
    Table 119. Celyad Major Business
    Table 120. Celyad CAR T-Cell Therapy Agents Product and Services
    Table 121. Celyad CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 122. Global Key Players of CAR T-Cell Therapy Agents Upstream (Raw Materials)
    Table 123. CAR T-Cell Therapy Agents Typical Customers
List of Figure
    Figure 1. CAR T-Cell Therapy Agents Picture
    Figure 2. World CAR T-Cell Therapy Agents Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World CAR T-Cell Therapy Agents Total Market Size (2019-2030) & (USD Million)
    Figure 4. World CAR T-Cell Therapy Agents Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World CAR T-Cell Therapy Agents Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company CAR T-Cell Therapy Agents Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company CAR T-Cell Therapy Agents Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company CAR T-Cell Therapy Agents Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company CAR T-Cell Therapy Agents Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company CAR T-Cell Therapy Agents Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company CAR T-Cell Therapy Agents Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company CAR T-Cell Therapy Agents Revenue (2019-2030) & (USD Million)
    Figure 13. CAR T-Cell Therapy Agents Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
    Figure 16. World CAR T-Cell Therapy Agents Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
    Figure 18. China CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
    Figure 23. India CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of CAR T-Cell Therapy Agents by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR T-Cell Therapy Agents Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR T-Cell Therapy Agents Markets in 2023
    Figure 27. United States VS China: CAR T-Cell Therapy Agents Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: CAR T-Cell Therapy Agents Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World CAR T-Cell Therapy Agents Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World CAR T-Cell Therapy Agents Market Size Market Share by Type in 2023
    Figure 31. CD19-targeted
    Figure 32. BCMA-targeted
    Figure 33. World CAR T-Cell Therapy Agents Market Size Market Share by Type (2019-2030)
    Figure 34. World CAR T-Cell Therapy Agents Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World CAR T-Cell Therapy Agents Market Size Market Share by Application in 2023
    Figure 36. Lymphoma
    Figure 37. Multiple Myeloma
    Figure 38. CAR T-Cell Therapy Agents Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Companies Mentioned

Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad